https://thepriorityreview.com/news/eli-lilly-orforglipron-dapagliflozin-phase-3-results2026-10-16T18:16:02.953Z https://thepriorityreview.com/news/new-phase-3-trials-week-of-2026-10-122026-10-16T14:03:45.688Z https://thepriorityreview.com/news/phase-3-results-week-of-2026-10-122026-10-16T14:03:27.912Z https://thepriorityreview.com/news/fda-actions-week-of-2026-10-122026-10-16T14:03:10.239Z https://thepriorityreview.com/news/sanofi-itepekimab-aerify-2-copd-results2026-10-15T21:09:54.215Z https://thepriorityreview.com/news/roche-obinutuzumab-childhood-nephrotic-syndrome-results2026-10-15T21:09:50.447Z https://thepriorityreview.com/news/united-therapeutics-teton-2-inhaled-treprostinil-ipf-results2026-10-15T18:06:59.635Z https://thepriorityreview.com/news/sanofi-aerify-1-itepekimab-copd-results-posted2026-10-15T18:06:20.868Z https://thepriorityreview.com/news/fda-expands-anktiva-bcg-unresponsive-nmibc-papillary2026-10-14T18:49:25.190Z https://thepriorityreview.com/news/lees-ciprofloxacin-fluocinolone-aoe-results2026-10-13T18:05:14.268Z https://thepriorityreview.com/news/roche-impower030-atezolizumab-nsclc-results2026-10-12T18:08:11.372Z https://thepriorityreview.com/news/issue-week-of-2026-10-052026-10-12T04:02:19.025Z https://thepriorityreview.com/news/new-phase-3-trials-week-of-2026-10-052026-10-12T04:02:05.443Z https://thepriorityreview.com/news/phase-3-results-week-of-2026-10-052026-10-12T04:01:49.091Z https://thepriorityreview.com/news/fda-actions-week-of-2026-10-052026-10-12T04:01:32.395Z https://thepriorityreview.com/news/fda-approves-hovilpri-pritelivir-hsv-immunocompromised2026-10-11T22:16:21.244Z https://thepriorityreview.com/news/issue-week-of-2026-09-282026-10-11T20:04:25.269Z https://thepriorityreview.com/news/sanofi-menacyw-conjugate-vaccine-infants-results-posted2026-10-09T12:54:46.029Z https://thepriorityreview.com/news/janssen-aticaprant-ventura-lt-results-posted2026-10-09T12:54:07.339Z https://thepriorityreview.com/news/cms-publishes-2027-medicare-advantage-part-d-star-ratings2026-10-09T12:52:49.934Z https://thepriorityreview.com/news/fda-approves-tucatinib-trastuzumab-pertuzumab-her2-positive-breast-cancer2026-10-09T12:46:43.430Z https://thepriorityreview.com/news/fda-approves-atezolizumab-chemotherapy-stage-iii-dmmr-colon-cancer2026-10-09T12:46:01.429Z https://thepriorityreview.com/news/new-phase-3-trials-week-of-2026-09-282026-10-09T12:35:16.402Z https://thepriorityreview.com/news/phase-3-results-week-of-2026-09-282026-10-09T12:35:13.904Z https://thepriorityreview.com/news/fda-actions-week-of-2026-09-282026-10-09T12:35:11.447Z https://thepriorityreview.com/news/fda-approves-autus-size-adjustable-pediatric-pulmonary-valve2026-10-02T08:47:43.448Z https://thepriorityreview.com/news/fda-approves-emcitate-tiratricol-mct8-deficiency2026-10-02T08:47:39.858Z https://thepriorityreview.com/news/fda-nonclinical-testing-terminology-direct-final-rule2026-10-02T08:47:36.338Z https://thepriorityreview.com/news/fda-approves-fayuvi-gene-therapy-sanfilippo-type-a2026-10-02T08:47:32.744Z https://thepriorityreview.com/terms2026-10-13T13:27:21.229Z https://thepriorityreview.com/privacy2026-10-13T13:27:16.850Z https://thepriorityreview.com/about2026-10-13T13:27:12.334Z